Significant contrasts exist between US and Transatlantic cancer treatment models. Generally , the United States approach relies more on advanced treatment and individualized plans, often at a greater cost . However, Transatlantic approaches prioritize early identification, comprehensive provision to fundamental care , and population-based well-bein